[ 🔔 📣 NEW PUBLICATION: EXECUTIVE SUMMARY OF THE CDDF ANNUAL CONFERENCE 2024]

The Cancer Drug Development Forum (CDDF) is delighted to announced that its executive summary of this year’s Annual Conference has been published today and is available to all our stakeholders.

This multi-stakeholder conference took place on 5-7 February 2024, bringing together the community of oncology drug development. The meeting explored and analyzed innovative approaches to accelerate oncology drug development, considering the changing paradigms and regulatory environment in the field. The program focused on real world evidence, decentralized care and trials, impact of recent regulatory changes, diversity in clinical trials, and drug and biomarker combinations in oncology.

To learn more about our discussions, read the executive summary and feel free to share your thoughts with us: CDDF AC 2024_Executive Summary_12Feb2024